Jump Financial’s Precision BioSciences DTIL Stock Holding History

Jump Financial’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$282K	Buy	51,273 +15,483	+43%	+$71.4K	﹤0.01%	1512
2025 Q4	$149K	Buy	+35,790	New	+$203K	﹤0.01%	1791
2022 Q3	–	Sell	-337	Closed	-$16K	–	1666
2022 Q2	$16K	Buy	+337	New	+$19.8K	﹤0.01%	1545
2021 Q3	–	Sell	-2,647	Closed	-$994K	–	1192
2021 Q2	$994K	Buy	2,647 +2,009	+315%	+$603K	0.1%	278
2021 Q1	$198K	Buy	+638	New	+$223K	0.02%	764

Other funds holding DTIL

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Jump Financial's DTIL Position: Q1 2026 in Review

Jump Financial increased its Precision BioSciences (DTIL) stake by 43% in Q1 2026, buying an estimated $71.4K and bringing the position to 51,273 shares worth $282K. The position accounts for ﹤0.01% of the portfolio, ranked #1512.

Jump Financial first reported a position in DTIL in Q1 2021 and has held it in 5 quarters since. The position peaked at $994K in Q2 2021. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

Jump Financial held 51,273 shares of Precision BioSciences worth $282K as of Q1 2026.
Jump Financial bought 15,483 Precision BioSciences shares in Q1 2026, an estimated $71.4K.
Precision BioSciences made up ﹤0.01% of Jump Financial's portfolio in Q1 2026, its #1512 holding.
Jump Financial first reported a position in Precision BioSciences in Q1 2021 and has held it in 5 quarters since.
Jump Financial's Precision BioSciences position peaked at $994K in Q2 2021.
78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.